|
SAAL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.183600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.443870E-02 |
| Normal-vs-Stage2 |
4.114500E-02 |
| Normal-vs-Stage3 |
3.330800E-01 |
| Normal-vs-Stage4 |
1.424810E-01 |
| Stage1-vs-Stage2 |
7.560400E-01 |
| Stage1-vs-Stage3 |
2.810400E-01 |
| Stage1-vs-Stage4 |
7.246800E-01 |
| Stage2-vs-Stage3 |
2.855200E-01 |
| Stage2-vs-Stage4 |
5.935000E-01 |
| Stage3-vs-Stage4 |
6.047400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.069000E-01 |
| Normal-vs-AfricanAmerican |
8.522600E-03 |
| Normal-vs-Asian |
3.670300E-02 |
| Caucasian-vs-AfricanAmerican |
4.471900E-02 |
| Caucasian-vs-Asian |
1.468450E-01 |
| AfricanAmerican-vs-Asian |
4.526800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.700220E-02 |
| Normal-vs-Female |
4.480100E-02 |
| Male-vs-Female |
3.281000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.640150E-02 |
| Normal-vs-Age(41-60Yrs) |
1.521230E-01 |
| Normal-vs-Age(61-80Yrs) |
1.366190E-01 |
| Normal-vs-Age(81-100Yrs) |
5.532000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.883240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.223600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.927800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.199600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.542200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.736200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.969000E-01 |
| Classical-VS-Follicular |
1.732240E-01 |
| Classical-VS-Other |
5.513600E-01 |
| Classical-VS-Normal |
6.032500E-02 |
| Tall-VS-Follicular |
1.299750E-01 |
| Tall-VS-Other |
4.070200E-01 |
| Tall-VS-Normal |
4.549800E-01 |
| Follicular-VS-Other |
9.783800E-01 |
| Follicular-VS-Normal |
1.074350E-02 |
| Other-VS-Normal |
1.545000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.462200E-02 |
| Normal-vs-N1 |
9.830200E-01 |
| N0-vs-N1 |
5.826100E-02 |
|
|
